Wright Medical Group NV (NASDAQ:WMGI) VP Sells $14,973.36 in Stock

Wright Medical Group NV (NASDAQ:WMGI) VP Julie Andrews sold 712 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $21.03, for a total transaction of $14,973.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Julie Andrews also recently made the following trade(s):

  • On Monday, June 3rd, Julie Andrews sold 1,447 shares of Wright Medical Group stock. The stock was sold at an average price of $30.65, for a total transaction of $44,350.55.

Shares of WMGI opened at $22.28 on Thursday. The firm has a market cap of $2.74 billion, a PE ratio of 240.33, a P/E/G ratio of 8.89 and a beta of 0.69. The company has a current ratio of 0.91, a quick ratio of 0.68 and a debt-to-equity ratio of 0.80. The firm has a fifty day simple moving average of $25.76 and a two-hundred day simple moving average of $29.52. Wright Medical Group NV has a 1-year low of $20.46 and a 1-year high of $32.86.

Wright Medical Group (NASDAQ:WMGI) last announced its earnings results on Wednesday, August 7th. The medical device company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. Wright Medical Group had a negative net margin of 14.65% and a positive return on equity of 1.38%. The business had revenue of $229.73 million during the quarter, compared to analyst estimates of $233.04 million. During the same period in the previous year, the business earned ($0.03) EPS. The company’s quarterly revenue was up 11.8% compared to the same quarter last year. As a group, research analysts forecast that Wright Medical Group NV will post 0.16 EPS for the current fiscal year.

Several hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of Wright Medical Group by 0.7% during the 2nd quarter. Vanguard Group Inc. now owns 11,390,529 shares of the medical device company’s stock valued at $339,666,000 after acquiring an additional 81,975 shares during the period. BlackRock Inc. grew its position in shares of Wright Medical Group by 4.8% during the 2nd quarter. BlackRock Inc. now owns 11,000,118 shares of the medical device company’s stock valued at $328,024,000 after acquiring an additional 501,510 shares during the period. Fisher Asset Management LLC grew its position in shares of Wright Medical Group by 2.4% during the 2nd quarter. Fisher Asset Management LLC now owns 2,889,564 shares of the medical device company’s stock valued at $86,167,000 after acquiring an additional 67,590 shares during the period. Redmile Group LLC grew its position in shares of Wright Medical Group by 13.3% during the 1st quarter. Redmile Group LLC now owns 2,874,100 shares of the medical device company’s stock valued at $90,390,000 after acquiring an additional 336,800 shares during the period. Finally, Nuveen Asset Management LLC bought a new stake in shares of Wright Medical Group during the 2nd quarter valued at $58,939,000.

A number of equities research analysts have weighed in on the stock. Oppenheimer decreased their target price on shares of Wright Medical Group from $34.00 to $29.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Wells Fargo & Co lowered shares of Wright Medical Group from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $28.00 to $23.00 in a research note on Monday, August 12th. Piper Jaffray Companies set a $27.00 target price on shares of Wright Medical Group and gave the company a “buy” rating in a research note on Friday, August 16th. Bank of America lowered shares of Wright Medical Group from a “buy” rating to a “neutral” rating and set a $25.00 target price for the company. in a research note on Friday, August 9th. Finally, BMO Capital Markets decreased their target price on shares of Wright Medical Group from $36.00 to $30.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Six analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Wright Medical Group presently has an average rating of “Buy” and a consensus price target of $30.50.

Wright Medical Group Company Profile

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Further Reading: Catch-Up Contributions

Insider Buying and Selling by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit